These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8445286)

  • 1. Antibody-mediated platelet activation.
    Kelton JG; Horsewood P
    J Lab Clin Med; 1993 Mar; 121(3):382-4. PubMed ID: 8445286
    [No Abstract]   [Full Text] [Related]  

  • 2. The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment.
    Kumpel BM; Wang Y; Griffiths HL; Hadley AG; Rook GA
    Hum Antibodies Hybridomas; 1995; 6(3):82-8. PubMed ID: 8597627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancing the potency of therapeutic monoclonal antibodies via Fc optimization.
    Stavenhagen JB; Gorlatov S; Tuaillon N; Rankin CT; Li H; Burke S; Huang L; Johnson S; Koenig S; Bonvini E
    Adv Enzyme Regul; 2008; 48():152-64. PubMed ID: 18177741
    [No Abstract]   [Full Text] [Related]  

  • 4. C1q augments platelet activation in response to aggregated Ig.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1997 Dec; 159(11):5594-8. PubMed ID: 9548501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Fc gamma RIIA gene polymorphism in human platelet activation by monoclonal antibodies.
    Bachelot C; Saffroy R; Gandrille S; Aiach M; Rendu F
    Thromb Haemost; 1995 Dec; 74(6):1557-63. PubMed ID: 8772237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activation via binding of monoclonal antibodies to the Fc gamma receptor II.
    Wilkinson JM; Hornby EJ; Authi KS
    Adv Exp Med Biol; 1993; 344():221-8. PubMed ID: 8209790
    [No Abstract]   [Full Text] [Related]  

  • 7. IgG-mediated enhancement of antibody responses is low in Fc receptor gamma chain-deficient mice and increased in Fc gamma RII-deficient mice.
    Wernersson S; Karlsson MC; Dahlström J; Mattsson R; Verbeek JS; Heyman B
    J Immunol; 1999 Jul; 163(2):618-22. PubMed ID: 10395649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc-receptor dependent platelet aggregation induced by monoclonal antibodies against platelet glycoprotein Ib or von Willebrand factor.
    Cauwenberghs N; Schlammadinger A; Vauterin S; Cooper S; Descheemaeker G; Tornai I; Deckmyn H
    Thromb Haemost; 2001 Apr; 85(4):679-85. PubMed ID: 11341505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble FcR block suppressor T cell activity at low concentration in vitro allowing isotype-specific antibody production.
    Simpson SD; Snider DP; Zettel LA; Kiyono H; Unkeless JC; Ernst PB
    Cell Immunol; 1996 Jan; 167(1):122-8. PubMed ID: 8548835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Suppression of FcRII by intravenously administerd IgG is dependent of preparation procedures of immunoglobulins].
    Greinacher A; Möckel M; Mueller-Eckhardt C
    Beitr Infusionsther Transfusionsmed; 1994; 32():211-3. PubMed ID: 9480090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanized mouse models of FcR clearance in immune platelet disorders.
    McKenzie SE
    Blood Rev; 2002 Mar; 16(1):3-5. PubMed ID: 11913983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of platelet aggregation induced by HLA-related antibodies.
    Brandt JT; Julius CJ; Osborne JM; Anderson CL
    Thromb Haemost; 1996 Nov; 76(5):774-9. PubMed ID: 8950789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fc receptor-dependent platelet activation results independently of glycoprotein complex IIb/IIIa].
    Greinacher A; Liebenhoff U; Kiefel V; Presek P; Mueller-Eckhardt C
    Beitr Infusionsther Transfusionsmed; 1994; 32():208-10. PubMed ID: 9480089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical use of immunoglobulins.
    McClelland DB; Yap PL
    Clin Haematol; 1984 Feb; 13(1):39-74. PubMed ID: 6233053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16).
    Hazenbos WL; Heijnen IA; Meyer D; Hofhuis FM; Renardel de Lavalette CR; Schmidt RE; Capel PJ; van de Winkel JG; Gessner JE; van den Berg TK; Verbeek JS
    J Immunol; 1998 Sep; 161(6):3026-32. PubMed ID: 9743367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies.
    Membre A; Wahl D; Latger-Cannard V; Max JP; Lacolley P; Lecompte T; Regnault V
    Haematologica; 2008 Apr; 93(4):566-73. PubMed ID: 18322249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new role for FcgammaRIIA in the potentiation of human platelet activation induced by weak stimulation.
    Canobbio I; Stefanini L; Guidetti GF; Balduini C; Torti M
    Cell Signal; 2006 Jun; 18(6):861-70. PubMed ID: 16169188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Platelet activation].
    Oda A; Ozaki K; Ikeda Y
    Tanpakushitsu Kakusan Koso; 1998 Sep; 43(12 Suppl):1863-9. PubMed ID: 9788194
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet FcgammaRIIA binds and internalizes IgG-containing complexes.
    Worth RG; Chien CD; Chien P; Reilly MP; McKenzie SE; Schreiber AD
    Exp Hematol; 2006 Nov; 34(11):1490-5. PubMed ID: 17046568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-human platelet tetraspanin (CD9) monoclonal antibodies induce platelet integrin alpha IIb beta 3 activation in a Fc receptor-independent fashion.
    Wu H; Li J; Peng L; Liu H; Wu W; Zhou Y; Hou Q; Kong D
    Chin Med J (Engl); 2001 Jan; 114(1):14-8. PubMed ID: 11779428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.